Article Text

Download PDFPDF
Original research
CT angiogram negative perimesencephalic subarachnoid hemorrhage: is a subsequent DSA necessary? A systematic review
  1. Midhun Mohan1,
  2. Abdurrahman Islim2,3,
  3. Louise Dulhanty1,
  4. Adrian Parry-Jones1,4,
  5. Hiren Patel1,4
  1. 1 Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, UK
  2. 2 Institute of Translational Medicine, University of Liverpool, Liverpool, UK
  3. 3 Department of Neurosurgery, Walton Centre NHS Foundation Trust, Liverpool, UK
  4. 4 Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
  1. Correspondence to Mr Hiren Patel, Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salfordm, UK; Hiren.Patel{at}srft.nhs.uk

Abstract

Background Perimesencephalic subarachnoid hemorrhage (PMSAH) is a benign subtype with distinct clinical-radiologic features. Digital subtraction angiography (DSA) remains the gold standard investigation for exclusion of a macrovascular cause, although increasingly more clinicians rely solely on CT angiography (CTA). The primary aim of this systematic review was to evaluate the current literature regarding the negative predictive value of CTA.

Methods A systematic search in concordance with the PRISMA checklist was performed for studies published between 2000 and 2018. Studies with ≥10 adult patients diagnosed on a non-contrast brain CT with a PMSAH, who underwent a negative CTA and were subsequently subject to a DSA, were included. Simple pooled analysis was performed to inform the negative predictive value (95% CI) of CTA and the risk of DSA- and CTA-related complications.

Results Eighteen studies (669 patients) were included. All patients were subject to at least one DSA, the first one mostly performed within 24 hours of CTA (68.6%). 144 patients (21.5%) underwent a second DSA and a third repeat DSA was performed in one patient. The overall negative predictive value of CTA was 99.0% (95% CI 97.8% to 99.5%). The risk of complications following DSA and CTA were 1.35% (3/222) and 0% (0/41), respectively.

Conclusions Undertaking a DSA after a negative CTA may not add any further diagnostic value in patients with PMSAH and may lead to net harm. This observation needs to be validated in a large-scale prospective multicenter study with complete case ascertainment and robust data on CTA and DSA complications.

  • computed tomography angiography
  • digital subtraction angiography
  • perimesencephalic
  • subarachnoid haemorrhage
  • systematic review

Statistics from Altmetric.com

Footnotes

  • MM and AI contributed equally.

  • Contributors MM, AI: study idea conception, protocol development, data collection, data analysis, manuscript writing/drafting. LD, AP-J: study idea conception, protocol development, manuscript writing/drafting. HP: study supervision, study idea conception, protocol development, manuscript writing/revision.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement Study data are available upon request from the corresponding author.

  • Patient consent for publication Not required.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.